Brian Topp - Concepedia

Author

Brian Topp

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

B. G. Topp, B. Topp, B.G. Topp, BRIAN TOPP, Brian G. Topp, Brian Gregory Topp, Brian Topp, Qi, Timothy, Topp, Brian

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Simon Fraser University Cornell University

About

Brian Topp is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, health sciences, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	544
2	Health Sciences	4	4	465
3	Cell Biology	3	3	406
4	Biology	1	1	56
5	Biostatistics	1	1	20

Brian Topp

Publications

Citations

H-Index

Page 1

	Year	Citations
β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats Diane T. Finegood, M. Dawn McArthur, David Kojwang, Diabetes	2001	373
A Model of β -Cell Mass, Insulin, and Glucose Kinetics: Pathways to Diabetes Brian Topp, Keith Promislow, GERDA DEVRIES, Journal of Theoretical Biology Metabolic SyndromeGlucose KineticsPhysiologyDiabetesβ -Cell Mass	2000	322
Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities Erica L. Bradshaw, Mary E. Spilker, Richard Zang, CPT Pharmacometrics & Systems Pharmacology	2019	85
Metabolic adaptations to chronic glucose infusion in rats Brian Topp, M. Dawn McArthur, Diane T. Finegood Diabetologia Metabolic SyndromeInsulin ManagementDiabetesPhysiologyGlucose Infusion	2004	67
Dynamics of insulin sensitivity, β-cell function, and β-cell mass during the development of diabetes in <i>fa</i>/<i>fa</i> rats Brian Topp, Laura L. Atkinson, Diane T. Finegood American Journal of Physiology-Endocrinology and Metabolism Glucose ModelCellular PhysiologyInsulin SignalingObesityMetabolic Syndrome	2007	56
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression Brian Topp, Madhav Channavazzala, Kapil Mayawala, Cancer Cell Disease ProgressionSolid TumorsCancer ManagementTumor DynamicsImmunology	2023	38
β‐cell deterioration – prospects for reversal or prevention Diane T. Finegood, Brian Topp Diabetes Obesity and Metabolism Cell DeathDegenerative PathologyCell ProliferationCellular SenescenceMedicine	2001	28
Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab Brian Topp, K. Thiagarajan, Dinesh P. de Alwis, Annals of Oncology	2021	26
Treatment with Sitagliptin or Metformin Does Not Increase Body Weight despite Predicted Reductions in Urinary Glucose Excretion Steven B. Waters, Brian Topp, Scott Q. Siler, Journal of Diabetes Science and Technology	2009	21
Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response Rukmini Kumar, Kannan Thiagarajan, Lakshmanan Jagannathan, CPT Pharmacometrics & Systems Pharmacology Single Average TumorSurgical OncologyCombination Checkpoint TherapyImmunologyPathology	2021	20

Page 1